Mainstreaming genetic counselling for genetic testing of BRCA1 and BRCA2 in ovarian cancer patients in Malaysia (MaGiC study)

被引：7
|
作者：
Yoon, S. Y. [1 ]
Bashah, N. S. Ahmad [1 ]
Wong, S. W. [1 ]
Mariapun, S. [2 ]
Hassan, T. [1 ]
Padmanabhan, H. [1 ]
Lim, J. [2 ]
Lau, S. Y. [2 ]
Rahman, N. [3 ]
Thong, M. K. [4 ]
Ch'Ng, G. S. [5 ]
Teo, S. H. [2 ]
Bleiker, E. [6 ]
Woo, Y. L. [7 ]
机构：
[1] Canc Res Malaysia, Familial Canc, Subang Jaya, Malaysia
[2] Canc Res Malaysia, Breast Canc Programme, Subang Jaya, Malaysia
[3] Inst Canc Res, Div Genet & Epidemiol, London, England
[4] Univ Malaya, Dept Pediat, Med Ctr, Kuala Lumpur, Malaysia
[5] Hosp Kuala Lumpur, Dept Genet, Kuala Lumpur, Malaysia
[6] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[7] Univ Malaya, Dept Obstet & Gynaecol, Med Ctr, Kuala Lumpur, Malaysia
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
10.1093/annonc/mdx729.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA4_PR
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The Contribution of BRCA1 and BRCA2 to Ovarian Cancer
    Ramus, Susan J.
    Gayther, Simon A.
    MOLECULAR ONCOLOGY, 2009, 3 (02) : 138 - 150
  • [32] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
  • [33] Hereditary ovarian cancer (BRCA1/2 mutation, genetic counselling, management)
    Giovannoni, Sara
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 18 - 19
  • [34] Pretest counselling post testing: Experiences of providing genetic counselling services to participants in a population based study of the prevalence and penetrance of BRCA1 and BRCA2 mutations in ovarian cancer.
    Randall, S
    Bradley, L
    Narod, S
    Murphy, KJ
    Rosen, B
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 377 - 377
  • [35] Hereditary ovarian cancer (BRCA1/2 mutation, genetic counselling, management)
    Giovannoni, Sara
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 14 - 14
  • [36] Factors associated with genetic testing in BRCA1 and BRCA2 mutation carriers with advanced ovarian carcinoma
    Norquist, B.
    Walsh, T.
    Pennil, C.
    Lee, M. K.
    Casadei, S.
    Thornton, A. M.
    Nord, A. S.
    Garcia, R.
    King, M. C.
    Swisher, E.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 435 - 435
  • [37] GENETIC VARIATION OF THE BRCA1 AND BRCA2 GENES IN MACEDONIAN PATIENTS
    Maleva, I
    Madjunkova, S.
    Bozhinovski, G.
    Smickova, E.
    Kondov, G.
    Spiroski, Z.
    Arsovski, A.
    Plaseska-Karanfilska, D.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2012, 15 : 81 - 85
  • [38] Population-Based Genetic Testing for BRCA1 and BRCA2 Reply
    Childers, Christopher P.
    Childers, Kimberly K.
    Maggard-Gibbons, Melinda
    Macinko, James
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [39] Genetic testing for BRCA1 and BRCA2 mutations in the Hispanic population.
    Erlichman, J
    Valero, V
    Lu, K
    Rivera, E
    Strong, L
    Arun, B
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S166 - S166
  • [40] Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria
    Singer, C. F.
    Muhr, D.
    Rappaport, C.
    Tea, M-K
    Gschwantler-Kaulich, D.
    Fink-Retter, A.
    Pfeiler, G.
    Berger, A.
    Sun, P.
    Narod, S. A.
    CLINICAL GENETICS, 2014, 85 (01) : 72 - 75
12345